Next Day Disclosure Return
Filed with HKEX · Stock code 9966 ·
6ix is reading this filing.
View original source (HKEXnews)Alphamab Oncology on 6ix
Earlier from Alphamab Oncology
- Voluntary announcement - ind approval by the FDA for a phase i clinical study of JSKN021
- Supplementary announcement on discloseable transaction
- Voluntary announcement - first patient dosed in phase iii clinical study of JSKN033 monotherapy for the treatment of cervical cancer
- Grant of award shares under the restricted share award scheme
- Voluntary announcement - latest research updates of JSKN003 presented at the 2026 esmo congress
Follow Alphamab Oncology into a list and get an email when it puts out news.
Follow Alphamab Oncology